22 Hrs
Source:
Financial Times
US probes Germany’s medical spending
The Section 301 investigation has intensified tensions between the United States and Europe over drug pricing policies. The probe focuses on addressing concerns about European pricing practices and their impact on U.S. pharmaceutical companies. This escalation highlights ongoing disputes related to international drug market regulation and trade negotiations.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)